Cited by 809Angiogenesis and VEGF in CancerLymphatic System and DiseasesMathematical Biology Tumor Growth

The DOI matches its Crossref record; 270 of the 271 references it cites were found in a registry or an index.

Mechanisms of normal and tumor-derived angiogenesis

Papetti, Michael, Herman, Ira M.·2002·American Journal of Physiology-Cell Physiology

DOI 10.1152/ajpcell.00389.2001

Open this paper in CoChat — free account

Abstract

Often those diseases most evasive to therapeutic intervention usurp the human body's own cellular machinery or deregulate normal physiological processes for propagation. Tumor-induced angiogenesis is a pathological condition that results from aberrant deployment of normal angiogenesis, an essential process in which the vascular tree is remodeled by the growth of new capillaries from preexisting vessels. Normal angiogenesis ensures that developing or healing tissues receive an adequate supply of nutrients. Within the confines of a tumor, the availability of nutrients is limited by competition among actively proliferating cells, and diffusion of metabolites is impeded by high interstitial pressure (Jain RK. Cancer Res 47: 3039–3051, 1987). As a result, tumor cells induce the formation of a new blood supply from the preexisting vasculature, and this affords tumor cells the ability to survive and propagate in a hostile environment. Because both normal and tumor-induced neovascularization fulfill the essential role of satisfying the metabolic demands of a tissue, the mechanisms by which cancer cells stimulate pathological neovascularization mimic those utilized by normal cells to foster physiological angiogenesis. This review investigates mechanisms of tumor-induced angiogenesis. The strategies used by cancer cells to develop their own blood supply are discussed in relation to those employed by normal cells during physiological angiogenesis. With an understanding of blood vessel growth in both normal and abnormal settings, we are better suited to design effective therapeutics for cancer.

Integrity signals

Registry

Crossref · 10.1152/ajpcell.00389.2001

Cites

270 of 270 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Mechanisms of angiogenesis
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvořàk, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,969
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Angiogenic factors.
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis
Gumbiner, B. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81279-9 · Cited by 3,471
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
OʼReilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,344
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,100
The Transforming Growth Factor-Beta Family
Massagué, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,041
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S. H., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,872
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U., Liotta, L. A., Falanga, V., & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,867
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Heldin, C., & Westermark, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1283 · Cited by 2,521
Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
Söker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,493
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,269
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,228
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J. A., Maisonpierre, P. C., Compton, D. L., Boland, P., Alexander, C., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,222
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G. G., Sanzo, K., Warren, T. G., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,058
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C. J. M., Escobedo, J. A., Ueno, H., Houck, K. A., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,019
Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway
Gerber, H. P., McMurtrey, A. E., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V. M., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30336 · Cited by 2,007
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martínez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg‐Buchholz, K., Fujiwara, Y., Gendron‐Maguire, M., Gridley, T., Wolburg, H., Risau, W., & Qin, Y. (1995) · Nature · doi:10.1038/376070a0 · Cited by 1,821
Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse
Hellström, M., Kalén, M., Lindahl, P., Abramsson, A., & Betsholtz, C. (1999) · Development · doi:10.1242/dev.126.14.3047 · Cited by 1,734
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., Mol, M. D., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,708
Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4
Wang, H. U., Chen, Z., & Anderson, D. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81436-1 · Cited by 1,684
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells
Derynck, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., BELL, J. R., Assoian, R. K., Roberts, A. B., Sporn, M. B., & Goeddel, D. V. (1985) · Nature · doi:10.1038/316701a0 · Cited by 1,667
Isolation of a tumor factor responsible for angiogenesis
Folkman, J., Merler, E., Abernathy, C., & Williams, G. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.133.2.275 · Cited by 1,663
Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
Waltenberger, J. L., Claesson, L., Siegbahn, A., Shibuya, M., & Heldin, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,661
Cachectin and tumour necrosis factor as two sides of the same biological coin
Beutler, B., & Cerami, A. (1986) · Nature · doi:10.1038/320584a0 · Cited by 1,633
The Human Hematopoietic Colony-Stimulating Factors
Clark, S., & Kamen, R. (1987) · Science · doi:10.1126/science.3296190 · Cited by 1,630
Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3
Brooks, P. C., Strömblad, S., Sanders, L. C., Schalscha, T. V., Aimes, R. T., Stetler‐Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,566
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D. S., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,437
Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.
Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W. M., Fang, G. H., Dumont, D., Breitman, M. L., & Alitalo, K. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3566 · Cited by 1,420
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,357
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. T., Yancopoulos, G. D., & McDonald, D. M. (1999) · Science · doi:10.1126/science.286.5449.2511 · Cited by 1,350
Definition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,310
Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis
Carmeliet, P., Lampugnani, M. G., Moons, L., Breviario, F., Compernolle, V., Bono, F., Balconi, G., Spagnuolo, R., Oosthuyse, B., Dewerchin, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81010-7 · Cited by 1,284
Structural Characterization and Biological Functions of Fibroblast Growth Factor
Gospodarowicz, D., Ferrara, N., Schweigerer, L., & Neufeld, G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-95 · Cited by 1,273
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.
Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., & Ellis, L. M. (1995) · PubMed · Cited by 1,265
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
Connolly, D. T., Heuvelman, D. M., Nelson, R. M., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., & Feder, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114322 · Cited by 1,265
Neuropilin is a semaphorin III receptor.
Kolodkin, A., Levengood, D. V., Rowe, E. G., Tai, Y.-T., Giger, R., & Ginty, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80535-8 · Cited by 1,262
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.
Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N. L., Wahl, L. M., Roberts, A. B., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5788 · Cited by 1,256
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., & Keshet, E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5028 · Cited by 1,234
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
Millauer, B., Shawver, L. K., Plate, K. H., Risaui, W., & Ullrich, A. (1994) · Nature · doi:10.1038/367576a0 · Cited by 1,225
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V. P., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,207
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
Achen, M. G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A. A., Wilks, A. F., Alitalo, K. K., & Stacker, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.548 · Cited by 1,203
Molecular and biological properties of vascular endothelial growth factor
Ferrara, N. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900019 · Cited by 1,153
Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III
He, Z., & Tessier‐Lavigne, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80534-6 · Cited by 1,137
Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities.Preprint
Levéen, P., Pekny, M., Gebré‐Medhin, S., Swolin, B., Larsson, E., & Betsholtz, C. (1994) · Genes & Development · doi:10.1101/gad.8.16.1875 · Cited by 1,130
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35712-0 · Cited by 1,127
Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
Park, J. E., Chen, H. H., Winer, J., Houck, K. A., & Ferrara, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47298-5 · Cited by 1,112
THE EPHRINS AND EPH RECEPTORS IN NEURAL DEVELOPMENT
Flanagan, J. G., & Vanderhaeghen, P. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.309 · Cited by 1,091
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.
Good, D. J., Polverini, P. J., Rastinejad, F., Beau, M. M. L., Lemons, R. S., Frazier, W. A., & Bouck, N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,051
Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice
Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S., & Akhurst, R. J. (1995) · Development · doi:10.1242/dev.121.6.1845 · Cited by 1,029
Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.
Maglione, D., Guerriero, V., Viglietto, G., Bovi, P. D., & Persico, M. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9267 · Cited by 998
Tumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996
Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice.Preprint
Soriano, P. M. (1994) · Genes & Development · doi:10.1101/gad.8.16.1888 · Cited by 988
Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.
Dumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A., & Breitman, M. L. (1994) · Genes & Development · doi:10.1101/gad.8.16.1897 · Cited by 985
Regulators Of Angiogenesis
Klagsbrun, M., & D'Amore, P. A. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001245 · Cited by 983
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
Lyons, R. M., Keski‐Oja, J., & Moses, H. L. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.106.5.1659 · Cited by 969
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
Robinson, C. J., & Stringer, S. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.853 · Cited by 944
Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., & Klagsbrun, M. (1984) · Science · doi:10.1126/science.6199844 · Cited by 932
Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells
Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F., & Vallée, B. L. (1985) · Biochemistry · doi:10.1021/bi00341a030 · Cited by 923
Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.
Sato, Y., & Rifkin, D. B. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.109.1.309 · Cited by 908
A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane.
Folkman, J., Klagsbrun, M., Sasse, J., Wadzinski, M., Ingber, D. E., & Vlodavsky, I. (1988) · PubMed Central · Cited by 875
Interleukin-4: a prototypic immunoregulatory lymphokine
Paul, W. E. (1991) · Blood · doi:10.1182/blood.v77.9.1859.1859 · Cited by 870
Signal Transduction and Signal Modulation by Cell Adhesion Receptors: The Role of Integrins, Cadherins, Immunoglobulin-Cell Adhesion Molecules, and Selectins
Aplin, A. E., Howe, A. K., Alahari, S. K., & Juliano, R. L. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01359-0 · Cited by 858
Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro.
Davies, P. F., Remuzzi, A., Gordon, E. J., Dewey, C. F., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.7.2114 · Cited by 848
Basic fibroblast growth factor induces angiogenesis in vitro.
Montesano, R., Vassalli, J. D., Baird, A., Guillemin, R., & Orci, L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7297 · Cited by 844
Transforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth Factor
Schreiber, A. B., Winkler, M. E., & Derynck, R. (1986) · Science · doi:10.1126/science.2422759 · Cited by 844
A requirement for neuropilin-1 in embryonic vessel formation
Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T., & Fujisawa, H. (1999) · Development · doi:10.1242/dev.126.21.4895 · Cited by 844
Eph Receptors and Ligands Comprise Two Major Specificity Subclasses and Are Reciprocally Compartmentalized during Embryogenesis
Gale, N. W., Holland, S. J., Valenzuela, D. M., Flenniken, A. M., Pan, L., Ryan, T. E., Henkemeyer, M. J., Strebhardt, K., Hirai, H., Wilkinson, D. G., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80276-7 · Cited by 839
Specificity, diversity, and regulation in TGF‐β superfamily signaling
Piek, E., Heldin, C., & ten Dijke, P. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2105 · Cited by 837
Increased Vascularization in Mice Overexpressing Angiopoietin-1
Suri, C., McClain, J., Thurston, G., McDonald, D. M., Zhou, H., Oldmixon, E. H., Sato, T. N., & Yancopoulos, G. D. (1998) · Science · doi:10.1126/science.282.5388.468 · Cited by 818
Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V., Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K. K., & Eriksson, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2576 · Cited by 812
Specificity, diversity, and regulation in TGF-beta superfamily signaling.
Piek, E., HELDIN, C., & ten Dijke, P. (1999) · PubMed · Cited by 783
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.
Postlethwaite, A. E., Keski-Oja, J., Moses, H. L., & Kang, A. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.1.251 · Cited by 777
Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.
Quinn, T. P., Peters, K. G., de Vries, C. J. M., Ferrara, N., & Williams, L. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7533 · Cited by 754
New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
Holash, J. A., Wiegand, S. J., & Yancopoulos, G. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203035 · Cited by 752
An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes.
Orlidge, A., Saunders, K. B., Smith, S. R., & D'Amore, P. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4544 · Cited by 752
β3-integrin–deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
Hodivala‐Dilke, K., McHugh, K. P., Tsakiris, D. Α., Rayburn, H., Crowley, D. G., Ullman-Culleré, M., Ross, F. P., Coller, B. S., Teitelbaum, S. L., & Hynes, R. O. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5487 · Cited by 741
Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
Pepper, M. S. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00048-2 · Cited by 737
Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells
Esser, S., Lampugnani, M. G., Corada, M., Dejana, E., & Risau, W. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.13.1853 · Cited by 715
Symmetrical Mutant Phenotypes of the Receptor EphB4 and Its Specific Transmembrane Ligand ephrin-B2 in Cardiovascular Development
Gerety, S. S., Wang, H. U., Chen, Z., & Anderson, D. J. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80342-1 · Cited by 713
Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.
Fràter‐Schröder, M., Risau, W., Hallmann, R., Gautschi-Sova, P., & Böhlen, P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5277 · Cited by 698
Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 698
Embryonic mesodermal defects in α5 integrin-deficient mice
Yang, J. T., Rayburn, H., & Hynes, R. O. (1993) · Development · doi:10.1242/dev.119.4.1093 · Cited by 691
VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V., & Alitalo, K. K. (1996) · Development · doi:10.1242/dev.122.12.3829 · Cited by 687
Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
Chang, Y. S., di Tomaso, E., McDonald, D. M., Jones, R. C., Jain, R. K., & Munn, L. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14608 · Cited by 672
Role of tissue factor in embryonic blood vessel development
Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressèns, P., Vlaenderen, L. V., Demunck, H., Kasper, M. E., Breier, G., Evrard, P., et al. (1996) · Nature · doi:10.1038/383073a0 · Cited by 669
TGF-β Receptor Type II Deficiency Results in Defects of Yolk Sac Hematopoiesis and Vasculogenesis
Oshima, M., Oshima, H., & Taketo, M. M. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0259 · Cited by 651
Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv Integrins
Bader, B., Rayburn, H., Crowley, D. G., & Hynes, R. O. (1998) · Cell · doi:10.1016/s0092-8674(00)81618-9 · Cited by 649
The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development
Eliceiri, B. P., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6869 · Cited by 649
A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.
Senger, D. R., Perruzzi, C. A., Feder, J., & Dvorak, H. F. (1986) · PubMed · Cited by 646
Regulation of Angiogenesis in Vivo by Ligation of Integrin α5β1 with the Central Cell-Binding Domain of Fibronectin
Kim, S., Bell, K. S., Mousa, S. A., & Varner, J. A. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65005-5 · Cited by 642
A novel endothelial-specific membrane protein is a marker of cell-cell contacts.
Lampugnani, M. G., Resnati, M., Raiteri, M., Pigott, R., Pisacane, A., Houen, G., Ruco, L., & Dejana, E. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.118.6.1511 · Cited by 632
Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate
Bussolino, F., Wang, J., Defilippi, P., Turrini, F., Sanavio, F., Edgell, C. J., Aglietta, M., Arese, P., & Mantovani, A. (1989) · Nature · doi:10.1038/337471a0 · Cited by 631
Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding Activity
Brooks, P. C., Silletti, S., Schalscha, T. V., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone
Folkman, J., Langer, R., Linhardt, R. J., Haudenschild, C. C., & Taylor, S. (1983) · Science · doi:10.1126/science.6192498 · Cited by 619
Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
Pepper, M. S., Ferrara, N., Orci, L., & Montesano, R. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91276-i · Cited by 615
Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells.
Orlidge, A., & D'Amore, P. A. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.105.3.1455 · Cited by 614
Differentiation of endothelium
Risau, W. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615161 · Cited by 607
Synergistic Effect of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor on Angiogenesis In Vivo
Asahara, T., Bauters, C., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1995) · Circulation · doi:10.1161/01.cir.92.9.365 · Cited by 597
Protamine is an inhibitor of angiogenesis
Taylor, S., & Folkman, J. (1982) · Nature · doi:10.1038/297307a0 · Cited by 580
Vascular endothelial growth factor C induces angiogenesis in vivo
Cao, Y., Linden, P. A., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi, J.-H., Claesson, L., & Alitalo, K. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14389 · Cited by 570
Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor.
Cheresh, D. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6471 · Cited by 569
Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells.
Gospodarowicz, D., Abraham, J. A., & Schilling, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7311 · Cited by 563
Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
Senger, D. R., Ledbetter, S. R., Claffey, K. P., Papadopoulos-Sergiou, A., Peruzzi, C. A., & Detmar, M. J. (1996) · Europe PMC (PubMed Central) · Cited by 548
An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4
Tepper, R. I., Coffman, R. L., & Leder, P. (1992) · Science · doi:10.1126/science.1636093 · Cited by 544
Hemodynamic forces are complex regulators of endothelial gene expression
Resnick, N., & Cimbrone, M. A. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615157 · Cited by 539
Induction of human vascular endothelial stress fibres by fluid shear stress
Franke, R. P., Gräfe, M., Schnittler, H.-J., Seiffge, D., Mittermayer, C., & Drenckhahn, D. (1984) · Nature · doi:10.1038/307648a0 · Cited by 530
The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells.
Puri, M. C., Rossant, J., Alitalo, K. K., Bernstein, A., & Partanen, J. M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00276.x · Cited by 526
Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
Unemori, E., Ferrara, N., Bauer, E. A., & Amento, E. P. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041530317 · Cited by 526
Angiogenesis promoted by vascular endothelial growth factor: Regulation through α 1 β 1 and α 2 β 1 integrins
Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Papadopoulos-Sergiou, A., & Detmar, M. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13612 · Cited by 522
Vascular development: cellular and molecular regulation
Beck, L. H., & D'Amore, P. A. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141503 · Cited by 520
Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands
Holland, S. J., Gale, N. W., Mbamalu, G., Yancopoulos, G. D., Henkemeyer, M. J., & Pawson, T. J. (1996) · Nature · doi:10.1038/383722a0 · Cited by 516
A novel vascular endothelial growth factor encoded by Orf virus, VEGF‐E, mediates angiogenesis via signalling through VEGFR‐2 (KDR) but not VEGFR‐1 (Flt‐1) receptor tyrosine kinases
Meyer, M., Clauss, M. A., Lepple‐Wienhues, A., Waltenberger, J. L., Augustin, H. G., Ziche, M., Lanz, C., Büttner, M., Rziha, H., & Dehio, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.2.363 · Cited by 515
Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans
Sakaue-Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T., & Shibuya, M. (2001) · Blood · doi:10.1182/blood.v97.3.785 · Cited by 510
Eph Family Transmembrane Ligands Can Mediate Repulsive Guidance of Trunk Neural Crest Migration and Motor Axon Outgrowth
Wang, H. U., & Anderson, D. J. (1997) · Neuron · doi:10.1016/s0896-6273(00)81240-4 · Cited by 479
Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.
Yang, E. Y., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.731 · Cited by 464
Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
Rastinejad, F., Polverini, P. J., & Bouck, N. (1989) · Cell · doi:10.1016/0092-8674(89)90238-9 · Cited by 460
Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
Goto, F., Goto, K., Weindel, K., & Folkman, J. (1993) · PubMed · Cited by 459
Angiopoietin-1 induces sprouting angiogenesis in vitro
Koblizek, T. I., Weiss, C., Yancopoulos, G. D., Deutsch, U., & Risau, W. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70205-2 · Cited by 459
PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors.
Battegay, E. J., Rupp, J., Iruela‐Arispe, M. L., Sage, E. H., & Pech, M. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.125.4.917 · Cited by 456
Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth.
Peters, K. G., de Vries, C. J. M., & Williams, L. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8915 · Cited by 456
In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.
Mignatti, P., Tsuboi, R., Robbins, E. S., & Rifkin, D. B. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.2.671 · Cited by 453
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
Pepper, M. S., Belin, D., Montesano, R., Orci, L., & Vassalli, J. D. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.2.743 · Cited by 450
Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice.
Thompson, N. L., Flanders, K. C., Smith, J. M., Ellingsworth, L. R., Roberts, A. B., & Sporn, M. B. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.2.661 · Cited by 448
Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction.
Roberts, A. B., Lamb, L. C., Newton, D., Sporn, M. B., Larco, J. E. D., & Todaro, G. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.6.3494 · Cited by 448
Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.
Singh, R. K., Gutman, M., BUCANA, C. D., Sanchez, R. R., Llansa, N., & Fidler, I. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4562 · Cited by 437
Circulating endothelial precursors: mystery, reality, and promise
Rafii, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8774 · Cited by 434
Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.
Jakeman, L. B., Winer, J., Bennett, G. L., Altar, C. A., & Ferrara, N. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115568 · Cited by 433
Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
Luca, M., Huang, S., Gershenwald, J. E., Singh, R. K., Reich, R., & Bar‐Eli, M. (1997) · Europe PMC (PubMed Central) · Cited by 414
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
Millauer, B., Longhi, M. P., Plate, K. H., Shawver, L. K., Risau, W., Ullrich, A., & Strawn, L. M. (1996) · PubMed · Cited by 413
tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors.
Dumont, D., Yamaguchi, T. P., Conlon, R. A., Rossant, J., & Breitman, M. L. (1992) · PubMed · Cited by 410
Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs
Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H., & Fujisawa, H. (1995) · Development · doi:10.1242/dev.121.12.4309 · Cited by 410
Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2
Eichmann, A., Corbel, C., Nataf, V., Vaigot, P., Bréant, C., & Douarin, N. M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5141 · Cited by 401
Basic Fibroblast Growth Factor Upregulates the Expression of Vascular Endothelial Growth Factor in Vascular Smooth Muscle Cells
Stavri, G. T., Zachary, I. C., Baskerville, P., Martin, J. F., & Erusalimsky, J. D. (1995) · Circulation · doi:10.1161/01.cir.92.1.11 · Cited by 397
Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis
Eliceiri, B. P., Klemke, R. L., Strömblad, S., & Cheresh, D. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.5.1255 · Cited by 396
Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.
Lee, J., Gray, A., Yuan, J., Luoh, S.-M., Avraham, H. K., & Wood, W. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1988 · Cited by 396
Role of prostaglandin E1 and copper in angiogenesis.
Ziche, M., Jones, J. J., & Gullino, P. M. (1982) · PubMed · Cited by 394
Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms.
Leavesley, D. I., Schwartz, M. A., Rosenfeld, M., & Cheresh, D. A. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.121.1.163 · Cited by 391
Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis.
Strömblad, S., Becker, J. C., Yebra, M., Brooks, P. C., & Cheresh, D. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118808 · Cited by 382
Vasculogenesis, Angiogenesis, and Growth Factors: Ephrins Enter the Fray at the Border
Yancopoulos, G. D., Klagsbrun, M., & Folkman, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81426-9 · Cited by 379
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
Ogawa, K., Pasqualini, R., Lindberg, R. A., Kain, R., Freeman, A. L., & Pasquale, E. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204004 · Cited by 376
A Novel Endothelial Cell Surface Receptor Tyrosine Kinase with Extracellular Epidermal Growth Factor Homology Domains
Partanen, J. M., Armstrong, E., Mäkelä, T. P., Korhonen, J., Sandberg, M., Renkonen, R., Knuutila, S., Huebner, K., & Alitalo, K. K. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1698 · Cited by 373
Kringle Domains of Human Angiostatin
Cao, Y., Ji, R. W., Davidson, D. J., Schaller, J., Marti, D. N., Söhndel, S., McCance, S. G., O’Reilly, M. S., Llinás, M., & Folkman, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29461 · Cited by 369
Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions
Lawrence, D. A., Pircher, R., & Jullien, P. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91239-2 · Cited by 365
Phosphorylation of the endothelial nitric oxide synthase at Ser‐1177 is required for VEGF‐induced endothelial cell migration
Dimmeler, S., Dernbach, E., & Zeiher, A. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01657-4 · Cited by 363
Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis
Pandey, A., Shao, H., Marks, R. M., Polverini, P. J., & Dixit, V. M. (1995) · Science · doi:10.1126/science.7536959 · Cited by 363
The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis
Ray, J., & Stetler‐Stevenson, W. G. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07112062 · Cited by 360
Persico MG.Isolation of a human placenta cDNA coding for a potein related to the vascular premeability factor
Maglione, D. (1991) · Medical Entomology and Zoology · Cited by 352
Neuropilin-1 Is a Placenta Growth Factor-2 Receptor
Migdal, M., Huppertz, B., Tessler, S., Comforti, A., Shibuya, M., Reich, R., Baumann, H., & Neufeld, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22272 · Cited by 351
Mice Lacking the Vascular Endothelial Growth Factor-B Gene ( Vegfb ) Have Smaller Hearts, Dysfunctional Coronary Vasculature, and Impaired Recovery From Cardiac Ischemia
Bellomo, D., Headrick, J. P., Silins, G. U., Paterson, C. A., Thomas, P. S., Gartside, M. G., Mould, A. W., Cahill, M. M., Tonks, I. D., Grimmond, S. M., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.2.e29 · Cited by 351
Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy.
Borgström, P., Hillan, K. J., Sriramarao, P., & Ferrara, N. (1996) · PubMed · Cited by 331
Compensation by Fibroblast Growth Factor 1 (FGF1) Does Not Account for the Mild Phenotypic Defects Observed in FGF2 Null Mice
Miller, D. L., Ortega, S., Bashayan, O., Basch, R. S., & Basilico, C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2260-2268.2000 · Cited by 326
Inhibition of Cell Motility by Interferon
Brouty‐Boyé, D., & Zetter, B. R. (1980) · Science · doi:10.1126/science.6154315 · Cited by 325
Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair.
Pierce, G. F., Tarpley, J. E., Yanagihara, D. L., Mustoe, T. A., Fox, G. M., & Thomason, A. (1992) · PubMed Central · Cited by 324
Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis.
Hughes, S., Yang, H., & Chan‐Ling, T. (2000) · PubMed · Cited by 320
Inhibitory action of transforming growth factor beta on endothelial cells.
Müller, G., Behrens, J., Nussbaumer, U., Böhlen, P., & Birchmeier, W. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5600 · Cited by 320
Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins
Kevil, C. G., Payne, D. K., Mire, E., & Alexander, J. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15099 · Cited by 318
Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene family
Tischer, E., Gospodarowicz, D., Mitchell, R., Silva, M. J., Schilling, J., Lau, K. H., Crisp, T., Fiddes, J. C., & Abraham, J. A. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92729-0 · Cited by 315
Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14.
Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O. N., Alitalo, K. K., Vecchio, S. D., Lei, K. J., Chou, J. Y., & Persico, M. G. (1993) · PubMed · Cited by 313
Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family.
Orlandini, M., Marconcini, L., Ferruzzi, R., & Oliviero, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11675 · Cited by 313
Differential Binding of Vascular Endothelial Growth Factor B Splice and Proteolytic Isoforms to Neuropilin-1
Mäkinen, T., Olofsson, B., Kärpänen, T., Hellman, U., Söker, S., Klagsbrun, M., Eriksson, U., & Alitalo, K. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21217 · Cited by 310
An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization
Drake, C. J., Cheresh, D. A., & Little, C. D. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.7.2655 · Cited by 307
Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus
Lyttle, D. J., Fraser, K. M., Fleming, S. B., Mercer, A. A., & Robinson, A. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.84-92.1994 · Cited by 303
Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
Streit, M., Riccardi, L., Velasco, P., Brown, L. F., Hawighorst, T., BORNSTEIN, P. K., & Detmar, M. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14888 · Cited by 303
The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors
Moses, M. A. (1997) · Stem Cells · doi:10.1002/stem.150180 · Cited by 301
Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor
Cao, Y., Chen, H., Zhou, L., Chiang, M., Anand‐Apte, B., Weatherbee, J. A., Wang, Y., Fang, F., Flanagan, J. G., & Tsang, M. L.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3154 · Cited by 299
Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro.
Nicosia, R. F., Nicosia, S. V., & Smith, M. (1994) · PubMed Central · Cited by 295
Purification and Characterization of a Naturally Occurring Vascular Endothelial Growth Factor · Placenta Growth Factor Heterodimer
DiSalvo, J., BAYNE, M. L., Conn, G., Kwok, P., Trivedi, P. G., Soderman, D. D., Palisi, T. M., Sullivan, K. A., & Thomas, K. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7717 · Cited by 295
Inhibition of endothelial cell proliferation by gamma-interferon.
Friesel, R. E., Komoriya, A., & Maciag, T. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.104.3.689 · Cited by 290
Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells
Lampugnani, M. G., Corada, M., Andriopoulou, P., Esser, S., Risau, W., & Dejana, E. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.17.2065 · Cited by 286
FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.
Pajusola, K., Aprelikova, O. N., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R., & Alitalo, K. K. (1992) · PubMed · Cited by 285
Human endothelial cells are chemotactic to endothelial cell growth factor and heparin.
Terranova, V. P., diFlorio‐Alexander, R. M., Lyall, R. M., Hic, S., Friesel, R. E., & Maciag, T. (1985) · The Journal of Cell Biology · doi:10.1083/jcb.101.6.2330 · Cited by 280
Vascular endothelial grouth facter B, a novel growth facter for endothelial cells
Olffson, B. (1996) · Medical Entomology and Zoology · Cited by 279
c- fos -induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro
Marconcini, L., Marchiò, S., Morbidelli, L., Cartocci, E., Albini, A., Ziche, M., Bussolino, F., & Oliviero, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9671 · Cited by 276
Fibroblast growth factors
Thomas, K. A. (1987) · The FASEB Journal · doi:10.1096/fasebj.1.6.3315806 · Cited by 273
TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler‐Stevenson, W. G., & Albini, A. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980119)75:2 · Cited by 272
Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
Saaristo, A. M., Kärpänen, T., & Alitalo, K. K. (2000) · Oncogene · doi:10.1038/sj.onc.1203969 · Cited by 266
Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V
Cui, J., O’Shea, K. S., Purkayastha, A. A., Saunders, T. L., & Ginsburg, D. (1996) · Nature · doi:10.1038/384066a0 · Cited by 261

Flagged first, then by citations

1 of the 271 references couldn’t be matched to a known paper.

Research works printed but not linked: 32

Ambs S, 1999, Cancer Res, 59, 5773
Borgstrom P, 1996, Cancer Res, 56, 4032
Clark RA, 1996, Am J Pathol, 148, 1407
Compagni A, 2000, Cancer Res, 60, 7163
Deroanne CF, 1997, Cancer Res, 57, 5590
Dumont DJ, 1992, Oncogene, 7, 1471
Dvorak HF, 1995, Am J Pathol, 146, 1029
Esser S, 1998, J Cell Sci, 110, 2065
Folkman J, 1988, Am J Pathol, 130, 393
Gately S, 1996, Cancer Res, 56, 4887
Goto F, 1993, Lab Invest, 69, 508
Healy AM, 1992, Eur J Cell Biol, 59, 56
Hughes S, 2000, Invest Ophthalmol Vis Sci, 41, 1217
Jain RK., 1987, Cancer Res, 47, 3039
Kitsukawa T, 1995, J Biol Chem, 121, 4309
Kohn S, 1992, Lab Invest, 67, 596
Korhonen J, 1994, Oncogene, 9, 395
Luca M, 1997, Am J Pathol, 151, 1105
Maglione D, 1993, Oncogene, 8, 925
Merwin JR, 1991, Am J Pathol, 138, 37
Millauer B, 1996, Cancer Res, 56, 1615
Nicosia RF, 1994, Am J Pathol, 145, 1023
Pajusola K, 1992, Cancer Res, 52, 5738
Pierce GF, 1992, Am J Pathol, 140, 1375
Senger DR, 1996, Am J Pathol, 149, 293
Senger DR, 1986, Cancer Res, 46, 5629
Takahashi Y, 1995, Cancer Res, 55, 3964
Tanaka T, 1998, Cancer Res, 58, 3362
Todaro GJ, 1990, Semin Cancer Biol, 1, 257
Topp MS, 1995, Cancer Res, 55, 2173
Vlodavsky I, 2000, Isr Med Assoc J, 2, 37
Ziche M, 1982, J Natl Cancer Inst, 69, 475

Sorted by citations

Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Adipose tissue remodeling and obesity
Sun, K., Kusminski, C. M., & Scherer, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45887 · Cited by 1,941
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,144
Diabetes and Wound Angiogenesis
Okonkwo, U. A., & DiPietro, L. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071419 · Cited by 1,071
Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?
Kobayashi, H., Watanabe, R., & Choyke, P. L. (2014) · Theranostics · doi:10.7150/thno.7193 · Cited by 996

See all 809

Authors: Papetti, M., & Herman, I. M.
Affiliations: Tufts University (US)
ORCID: Herman, Ira M.
Venue: American Journal of Physiology-Cell Physiology
Publisher: American Physiological Society
Published: 2002-05-01
Volume: 282
Issue: 5
Pages: C947-C970
ISSN: 0363-6143 (ISSN-L)
1522-1563
DOI: 10.1152/ajpcell.00389.2001
OpenAlex: W2050499474
Cited by: 809
References: 271
Citations by year: 2026: 11 · 2025: 15 · 2024: 19 · 2023: 33 · 2022: 38 · 2021: 32 · 2020: 36 · 2019: 28 · 2018: 20 · 2017: 41 · 2016: 36 · 2015: 45 · 2014: 42 · 2013: 46 · 2012: 41
FWCI: 2.10
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Physiology-Cell Physiology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01gm055110-04)
National Eye Institute (R01EY009033, EY09033)
National Institute of General Medical Sciences (GM55110)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034928)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
Keywords: tumor angiogenesis, physiological angiogenesis, tumor blood supply, vascular remodeling, capillary proliferation, interstitial fluid pressure, tumor microenvironment, cancer metabolism
MeSH terms: Blood Vessels, Growth Substances, Humans, Models, Cardiovascular, Neoplasms, Neovascularization, Pathologic, Proteins, Receptors, Cell Surface, Neovascularization, Physiologic, Receptor Protein-Tyrosine Kinases, Angiopoietin-2, Receptors, TIE

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mechanisms of normal and tumor-derived angiogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks